HTLV-1 myelopathy after renal transplant and antiviral prophylaxis: the need for screening

[1]  D. Laydon,et al.  Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients , 2016, Retrovirology.

[2]  G. Deuschl,et al.  HTLV-1 associated myelopathy after renal transplantation. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  P. Ramanan,et al.  Donor‐Transmitted HTLV‐1‐Associated Myelopathy in a Kidney Transplant Recipient—Case Report and Literature Review , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  J. Neuberger,et al.  HTLV-1 in Solid-Organ Transplantation: Current Challenges and Future Management Strategies , 2012, Transplantation.

[5]  A. Gessain,et al.  Epidemiological Aspects and World Distribution of HTLV-1 Infection , 2012, Front. Microbio..

[6]  V. Soriano,et al.  Situación actual de la infección por el VIH-2 y el HTLV-1/2 en España: luces y sombras , 2005 .

[7]  C. Toro,et al.  [Current status of HIV-2 and HTLV-1/2 infection in Spain: lights and shades]. , 2005, Medicina clinica.

[8]  D. Derse,et al.  Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. , 2003, The Journal of infectious diseases.

[9]  J. J. Zarranz Imirizaldu,et al.  Post-transplantation HTLV-1 myelopathy in three recipients from a single donor , 2003 .

[10]  B. Rodés,et al.  Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus Type I from a single donor , 2003, Transplantation.

[11]  M. Tomonaga,et al.  Human T-lymphotropic virus type 1 infection. , 2000, Bailliere's best practice & research. Clinical haematology.

[12]  A. Manns,et al.  Human T-lymphotropic virus type I infection , 1999, The Lancet.

[13]  M. Baulac,et al.  Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. , 1990, The New England journal of medicine.